Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Capital Agency Corp. (AGNC), Annaly Capital Management, Inc. (NLY), ARMOUR Residential REIT, Inc. (ARR): Should You Be Worried About Your mREIT’s Compensation Structure?

Page 1 of 2

The mortgage REIT sector has seen a lot of volatility during the past few months, thanks to speculation about the Fed’s exit from the Agency MBS markets that started in the mid-May this year. Last week, the Fed finally signaled that it will start tapering its bond buying later in this year, and a complete halt will come by the middle of next year. I believe this news will further amplify the volatility in interest rates. While mortgage REIT investors have suffered tremendous losses, the top executives at these mREITs continue to enjoy elevated compensations, thanks to the compensation structures being followed there. I will feature some mREITs in this article whose top executives are busy ensuring maximum compensation for them rather than worrying about the stock price and the company’s fundamentals.

American Capital Agency Corp. (NASDAQ:AGNC)

Bloodbath for the mREIT investors

Mortgage REIT investors have suffered a lot at the hands of the speculations about the unwinding of the third round of quantitative easing.

Since the start of the current quarter, Annaly Capital Management, Inc. (NYSE:NLY), American Capital Agency Corp. (NASDAQ:AGNC) and ARMOUR Residential REIT, Inc. (NYSE:ARR) fell 18%, 25.5% and 28%, respectively. The entire sector has declined the most since the financial crisis of 2008.

Analysts believe “it’s going to take a couple of years of dividends to make up for the decline in the stock prices” of these mREITs. That’s a lot of time for you to claw back your losses. However, the top executives at most of the mREITs will continue to get elevated compensations despite the poor stock performance and weak fundamentals of their companies.

Elevated compensation levels

Would you be shocked to learn that the CEOs at some mortgage REITs are drawing even more compensation than the CEO’s of the country’s largest bank? Yes, that’s true.

Annaly Capital Management, Inc. (NYSE:NLY), the largest mortgage REIT, has a market cap of $12.8 billion and offers a return on equity of 10.9%. This is compared to JPMorgan Chase & Co. (NYSE:JPM)’s market cap of $202.5 billion and a return on equity of 11.55%. JPMorgan happens to be the largest bank in the US, but its CEO was paid $23 million last year, while Annaly Capital Management, Inc. (NYSE:NLY)’s CEO was paid $32 million, more than double the average compensation of the six largest banks in the US.

I’m sure this must have raised some eyebrows, particularly while investors are experiencing a bloodbath.

Why I believe compensation will remain elevated?

Now, I’m sure you must be wondering what makes me think that these elevated compensations will not discontinue. The answer is the compensation structure of the mortgage REITs. Most mortgage REITs, including American Capital Agency Corp. (NASDAQ:AGNC), Annaly Capital Management, Inc. (NYSE:NLY) and ARMOUR Residential REIT, Inc. (NYSE:ARR), compensate their top management on the basis of the assets they manage during the entire year.

During the first quarter, mortgage REITs raised $7.4 billion by selling shares. That’s the most in two years. ARMOUR Residential REIT, Inc. (NYSE:ARR) and American Capital Agency Corp. (NASDAQ:AGNC) Agency raised $444 million and $2 billion during the month of February. Since the offerings, American Capital Agency Corp. (NASDAQ:AGNC) and ARMOUR Residential REIT, Inc. (NYSE:ARR) have fallen 20% and 26%, respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!